Cimetidine and Ertugliflozin Interaction

Drug interaction information between Cimetidine and Ertugliflozin.

Cimetidine and Ertugliflozin have a documented moderate interaction in FDA labeling.

FDA drug labeling documents a moderate-severity interaction between Cimetidine and Ertugliflozin. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Cimetidine

H2 Receptor Antagonist

Drug B

Ertugliflozin

SGLT2 Inhibitor

How They Interact

Cimetidine interferes with the body's ability to get rid of metformin through the kidneys, which can cause the drug to build up to unsafe levels.

FDA Label Information

Drugs that Reduce Metformin Clearance Clinical Impact: The risk of lactic acidosis may increase due to concomitant use of drugs that interfere with common renal tubular transport systems involved in the renal elimination of metformin (e.g., organic cationic transporter-2 [OCT2] / multidrug and toxin extrusion [MATE] inhibitors such as ranolazine, vandetanib, dolutegravir, and cimetidine) which increase systemic exposure to metformin Intervention Consider the benefits and risks of concomitant use.

Ertugliflozin Also Interacts With

View all Ertugliflozin interactions →

Frequently Asked Questions

What SPL severity band is on file for Cimetidine + Ertugliflozin?

Compiled FDA labeling labels this pair moderate. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Cimetidine has 77 labeled pairs on file vs Ertugliflozin's 8. In the moderate band specifically: Cimetidine has 10 (also Empagliflozin, Empagliflozin/Linagliptin, Hydroxychloroquine, Linagliptin); Ertugliflozin has 6 (also Metformin, Topiramate, Dolutegravir, Ranolazine).

What mechanism field is on file for Cimetidine and Ertugliflozin?

Cimetidine interferes with the body's ability to get rid of metformin through the kidneys, which can cause the drug to build up to unsafe levels.

Cimetidine carries more major-labeled pairs than Ertugliflozin

SPL source-record counts only. This page's band is moderate · classes on file: Cimetidine (H2 Receptor Antagonist); Ertugliflozin (SGLT2 Inhibitor).

Cimetidine has 4 major-labeled pairs vs Ertugliflozin's 0. This page itself is in the moderate band, not the major band.

Cimetidine

4 major · 10 moderate · 63 minor · 77 total

Ertugliflozin

0 major · 6 moderate · 2 minor · 8 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.